GP
Ghansham Panjabi Baird Latest Price Targets & Analyst Ratings
Main Sector
Consumer Discretionary
Ratings Past Year
20
Avg Return
Past Year
Past Year
3.4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
50%
Neutral
50%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Consumer Discretionary
Healthcare
Industrials
Materials
Consumer Discretionary
Packaging & Containers
Healthcare
Medical Instruments & Supplies
Industrials
Specialty Business Services
Materials
Chemicals
Specialty Chemicals
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $125 |
15%
upside
| 2 | -8% |
0
%
| 4 Mar ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $60 |
19%
upside
| 1 | – |
–
| 18 Feb ‘26 3 months ago |
|
|
|
Outperform
Upgraded
| $50 |
22%
upside
| 2 | -4.9% |
0
%
| 7 Jan ‘26 5 months ago |
|
|
|
Neutral
Downgraded
| $35 |
4%
upside
| 1 | – |
–
| 7 Jan ‘26 5 months ago |
|
|
|
Neutral
Downgraded
| $18 |
64%
upside
| 2 | +0.32% |
0
%
| 7 Jan ‘26 5 months ago |
|
|
|
Neutral
Downgraded
| $42 |
0%
downside
| 1 | – |
–
| 18 Dec ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $145 |
23%
upside
| 1 | +11% |
0
%
| 3 Nov ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $50 |
7%
downside
| 1 | +35% |
0
%
| 13 Aug ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $110 |
10%
upside
| 2 | +8.8% |
–
| 23 Jul ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $125 |
3%
upside
| 2 | +0.32% |
0
%
| 3 Jul ‘25 11 months ago |
|
|
|
Outperform
Maintained
| $75 |
16%
upside
| 2 | +3.3% |
0
%
| 27 Jun ‘25 11 months ago |
|